These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Effects of the cortisol synthesis inhibitor metyrapone on the response to carbon dioxide challenge in panic disorder. Belgorodsky A, Knyazhansky L, Loewenthal U, Arbelle J, Cohen H, Benjamin J. Depress Anxiety; 2005 Jun; 21(3):143-8. PubMed ID: 16001448 [Abstract] [Full Text] [Related]
26. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain. Heim C, Ehlert U, Hanker JP, Hellhammer DH. Psychosom Med; 1998 Jun; 60(3):309-18. PubMed ID: 9625218 [Abstract] [Full Text] [Related]
27. Increased pituitary activation following metyrapone administration in post-traumatic stress disorder. Yehuda R, Levengood RA, Schmeidler J, Wilson S, Guo LS, Gerber D. Psychoneuroendocrinology; 1996 Jan; 21(1):1-16. PubMed ID: 8778898 [Abstract] [Full Text] [Related]
29. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters. Gonul AS, Cetinkalp S, Tunay S, Polat I, Simsek F, Aksoy B, Kizilates G, Erdogan Y, Coburn KL. J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659 [Abstract] [Full Text] [Related]
30. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy. Cleare AJ, Miell J, Heap E, Sookdeo S, Young L, Malhi GS, O'Keane V. J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777 [Abstract] [Full Text] [Related]
31. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results. Muhtz C, Wester M, Yassouridis A, Wiedemann K, Kellner M. J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095 [Abstract] [Full Text] [Related]
32. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. Calis M, Gökçe C, Ates F, Ulker S, Izgi HB, Demir H, Kirnap M, Sofuoglu S, Durak AC, Tutus A, Kelestimur F. J Endocrinol Invest; 2004 Jan; 27(1):42-6. PubMed ID: 15053242 [Abstract] [Full Text] [Related]
37. Sex differences in ACTH pulsatility following metyrapone blockade in patients with major depression. Young EA, Ribeiro SC, Ye W. Psychoneuroendocrinology; 2007 Jun; 32(5):503-7. PubMed ID: 17462829 [Abstract] [Full Text] [Related]
39. Overnight metyrapone and combined dexamethasone/metyrapone tests in post-traumatic stress disorder: preliminary findings. Kellner M, Otte C, Yassouridis A, Schick M, Jahn H, Wiedemann K. Eur Neuropsychopharmacol; 2004 Aug; 14(4):337-9. PubMed ID: 15163445 [Abstract] [Full Text] [Related]
40. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]